# Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening

> **NCT03482557** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 132 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** CESM
- **DEVICE:** MRI

## Key facts

- **NCT ID:** NCT03482557
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-17
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03482557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03482557, "Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03482557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*